SCREEN-AND-TREAT CERVICAL CANCER SCREENING STRATEGY USING HIGH-RISK HPV TESTING: EARLY EVALUATION FOR UGANDA

被引：0
|
作者：
Sultanov, M. [1 ]
van der Schans, J. [1 ]
Koot, J. A. R. [1 ]
de Zeeuw, J.
Nakisige, C. [2 ]
Greuter, M. J. W. [1 ]
Greuter, J. J. [3 ]
de Fouw, M. [3 ]
Stekelenburg, J. [1 ,3 ]
de Bock, G. H. [1 ]
机构：
[1] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands
[2] Uganda Canc Inst, Kampala, Uganda
[3] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE685
引用
收藏
页码：S186 / S186
页数：1
相关论文
共 50 条
  • [1] Early evaluation of ascreen-and-treat strategy using high-risk HPV testing for Uganda: Implications for screening and treatment
    Sultanov, Marat
    van der Schans, Jurjen
    Koot, Jaap A. R.
    Greuter, Marcel J. W.
    de Zeeuw, Janine
    Nakisige, Carolyn
    Beltman, Jogchum J.
    de Fouw, Marlieke
    Stekelenburg, Jelle
    de Bock, Geertruida H.
    JOURNAL OF GLOBAL HEALTH, 2024, 14
  • [2] Screen-and-treat colposcopy, a feasible public health strategy for cervical cancer early detection in high-risk population
    Marcial-Toledo, Selene
    Escobar, Alberto
    Valdivieso, Laura
    Gordillo, Karla
    Ferreira-Olvera, Laura
    Mazon-Ramirez, Juan Jose
    Sanchez-Ruiz, Juan Francisco
    Perez-Romero, Jorge
    Sanchez-Romano, Genaro
    Gutierrez-Delgado, Francisco
    ANNALS OF ONCOLOGY, 2006, 17 : 176 - 176
  • [3] LOGISTICS OF TIME REQUIRED TO IMPLEMENT A SCREEN-AND-TREAT STRATEGY USING POINT-OF-CARE HPV TESTING FOR THE PREVENTION OF CERVICAL CANCER
    Mbatani, Nomonde
    Saidu, Rakiya
    Castor, Delivette
    Boa, Rosalind
    Moodley, Jennifer
    Kuhn, Louise
    Denny, Lynette
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A195 - A195
  • [4] Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening
    Wei, Baojun
    Mei, Ping
    Huang, Shengkai
    Yu, Xueting
    Zhi, Tong
    Wang, Guojing
    Xu, Xiaotian
    Xiao, Lin
    Dong, Xin
    Cui, Wei
    VIROLOGY JOURNAL, 2020, 17 (01)
  • [5] Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening
    Baojun Wei
    Ping Mei
    Shengkai Huang
    Xueting Yu
    Tong Zhi
    Guojing Wang
    Xiaotian Xu
    Lin Xiao
    Xin Dong
    Wei Cui
    Virology Journal, 17
  • [6] Cervical cancer screening in a low-resource setting: a pilot study on an HPV-based screen-and-treat approach
    Kunckler, Margot
    Schumacher, Fanny
    Kenfack, Bruno
    Catarino, Rosa
    Viviano, Manuela
    Tincho, Eveline
    Tebeu, Pierre-Marie
    Temogne, Liliane
    Vassilakos, Pierre
    Petignat, Patrick
    CANCER MEDICINE, 2017, 6 (07): : 1752 - 1761
  • [7] The value of high-risk HPV testing in cervical cancer surveillance
    Chanana, Anita
    Aryasomayajula, Chinmayi
    Lai, Tiffany
    Cohen, Joshua
    Salani, Ritu
    Zakhour, Mae
    GYNECOLOGIC ONCOLOGY, 2022, 164 (01) : E8 - E8
  • [8] The role of high-risk HPV testing in cervical cancer surveillance
    Aryasomayajula, C.
    Chanana, A.
    Tandel, M.
    Kwan, L.
    Cohen, J. G.
    Lai, T. S.
    Salani, R.
    Zakhour, M.
    GYNECOLOGIC ONCOLOGY, 2022, 164 (02) : 357 - 361
  • [9] Cost effectiveness of high-risk HPV DNA testing for cervical cancer screening in South Africa
    Vijayaraghavan, Arthi
    Efrusy, Molly
    Lindeque, Gerhard
    Dreyer, Greta
    Santas, Christopher
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : 377 - 383
  • [10] ECONOMIC MODELING OF RISK-ADAPTED SCREEN-AND-TREAT STRATEGIES IN WOMEN AT HIGH-RISK FOR BREAST OR OVARIAN CANCER
    Danner, M.
    Mueller, D.
    Schmutzler, R.
    Rhiem, K.
    Engel, C.
    Stollenwerk, B.
    Stock, S.
    Wassermann, K.
    VALUE IN HEALTH, 2016, 19 (07) : A737 - A738
12345